Status of indoleamine-2,3-dioxygenase 1 in infiltrating ductal carcinoma of breast cancer: a new prognostic indicator for aggressive tumors - Université de Lille Accéder directement au contenu
Article Dans Une Revue World Cancer Research journal Année : 2021

Status of indoleamine-2,3-dioxygenase 1 in infiltrating ductal carcinoma of breast cancer: a new prognostic indicator for aggressive tumors

Résumé

The tryptophan pathway has been demonstrated to be involved in tumor progression. Increased expression of indoleamine 2,3-dioxygenases has been observed in several human tumors types, such as breast cancer. In order to study the role of IDO expression as a prognostic marker, the serum tryptophan and kynurenine concentrations and the ratio of kynurenine to tryptophan (K/T) of 165 subjects were compared, and correlations were established.
Fichier principal
Vignette du fichier
SALMI et al.pdf (1.04 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04481679 , version 1 (28-02-2024)
hal-04481679 , version 2 (13-03-2024)

Licence

Identifiants

Citer

T. Salmi, M. Dali-Sahi, B. Guermouche, N. Dennouni-Medjati, Benjamin Hennart, et al.. Status of indoleamine-2,3-dioxygenase 1 in infiltrating ductal carcinoma of breast cancer: a new prognostic indicator for aggressive tumors. World Cancer Research journal, 2021, World Cancer Research journal, 8, pp.e2098. ⟨10.32113/wcrj_20219_2098⟩. ⟨hal-04481679v2⟩

Collections

UNIV-LILLE
6 Consultations
2 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More